[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $alkb ALKB receives a positive recommendation from NICE for its birch pollen allergy tablet. Engagements and mentions are up, indicating growing interest in the company. ### About $alkb ALKB is a company that provides sublingual allergy treatments. ### Insights [#](/topic/$alkb/insights) - $alkb creators is up XXX% from the previous month. - $alkb mentions is up XXX% from the previous month. - $alkb Engagements hit a high of XXX for the day - $alkb Engagements hit an all time of XXX for the day ### Engagements: X [#](/topic/$alkb/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$alkb/time-series/interactions.tsv) **Current Value**: X **Daily Average**: XX **1 Month**: XXX +1,216% **1-Year High**: XXX on 2025-07-21 **1-Year Low**: X on 2025-05-09 | Social Network | X | | -------------- | - | | Engagements | X | ### Mentions: X [#](/topic/$alkb/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$alkb/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Week**: X +100% **1 Month**: X +200% **1-Year High**: X on 2025-05-12 **1-Year Low**: X on 2025-04-29 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$alkb/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$alkb/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $alkb in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1 Week**: X +100% **1 Month**: X +200% **1-Year High**: X on 2025-05-12 **1-Year Low**: X on 2025-04-29 **Top topics mentioned** In the posts about $alkb in the last XX hours [coins healthcare](/topic/coins-healthcare), [pollen](/topic/pollen), [birch](/topic/birch) ### Top Social Posts [#](/topic/$alkb/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$ALKB just received a positive recommendation from NICE the UKs health authority for its birch pollen allergy tablet Itulazax. Its the second such endorsement this year following one for its dust mite tablet Acarizax. With this ALK-Abello becomes the only provider of sublingual allergy treatments approved for use in the UKs public healthcare system (NHS). Unfortunately its also one of those great companies that always trades at too high a valuation for my taste. #StocksInFocus #Investing" [@investseekers](/creator/x/investseekers) on [X](/post/tweet/1947252778054606917) 2025-07-21 11:10:15 UTC 2640 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
ALKB receives a positive recommendation from NICE for its birch pollen allergy tablet. Engagements and mentions are up, indicating growing interest in the company.
ALKB is a company that provides sublingual allergy treatments.
Engagements 24-Hour Chart Data
Current Value: X
Daily Average: XX
1 Month: XXX +1,216%
1-Year High: XXX on 2025-07-21
1-Year Low: X on 2025-05-09
Social Network | X |
---|---|
Engagements | X |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +100%
1 Month: X +200%
1-Year High: X on 2025-05-12
1-Year Low: X on 2025-04-29
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $alkb in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Week: X +100%
1 Month: X +200%
1-Year High: X on 2025-05-12
1-Year Low: X on 2025-04-29
Top topics mentioned In the posts about $alkb in the last XX hours
coins healthcare, pollen, birch
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ALKB just received a positive recommendation from NICE the UKs health authority for its birch pollen allergy tablet Itulazax. Its the second such endorsement this year following one for its dust mite tablet Acarizax. With this ALK-Abello becomes the only provider of sublingual allergy treatments approved for use in the UKs public healthcare system (NHS). Unfortunately its also one of those great companies that always trades at too high a valuation for my taste. #StocksInFocus #Investing"
@investseekers on X 2025-07-21 11:10:15 UTC 2640 followers, XXX engagements
/topic/$alkb